1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. JOINT PAIN INJECTIONS MARKET BY TYPE
5.1. Introduction
5.2. Corticosteroid
5.3. Hyaluronic Acid Injections
5.4. Platelet Rich Plasma (PRP) Injections
5.5. Others
6. JOINT PAIN INJECTIONS MARKET BY JOINT TYPE
6.1. Introduction
6.2. Knee Joint
6.3. Hands & Wrist Joint
6.4. Hip Joint
6.5. Others
7. JOINT PAIN INJECTIONS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Others
8. JOINT PAIN INJECTIONS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Italy
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Sanofi
10.2. Seikagaku Corporation
10.3. Bioventus
10.4. Anika Therapeutics, Inc.
10.5. Pacira BioSciences, Inc.
10.6. Dr. Reddy's Laboratories Ltd
10.7. Zimmer Biomet
10.8. Pfizer Inc
10.9. Teva Pharmaceutical Industries Ltd.
10.10. Ferring Pharmaceuticals
10.11. Eli Lilly And Company
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES